Technology | Magnetic Resonance Imaging (MRI) | December 11, 2017

Saturn X Gradient provides 30 percent increase in SNR during neuro MR exams; system also offers enhanced cardiac capabilities

Toshiba Vantage Galan 3T XGO Edition MRI Features New Advanced Gradient

MRI of the brain performed on the Galan 3T utilizing the 32-channel Head SPEEDER Coil


December 11, 2017 — Toshiba Medical, a Canon Group company, demonstrated the Vantage Galan 3T XGO Edition magnetic resonance imaging (MRI) with the all-new Saturn X Gradient, pending U.S. Food and Drug Administration (FDA) 510(k) clearance, at the 2017 Radiological Society of North America (RSNA) annual meeting, Nov. 26 – Dec. 1 in Chicago. The Saturn X Gradient features an advanced strength of 45 mT/m (milliTesla per meter) to offer healthcare providers fast, higher-resolution imaging, while continuing to deliver streamlined workflow and patient comfort.

The Saturn X Gradient on the Galan 3T XGO Edition comes with Toshiba Medical’s PUREGradient digital technology, which can provide up to 30 percent improved signal-to-noise ratio (SNR) for brain diffusion weighted imaging (DWI), resulting in even higher-resolution neuro images than previously offered. The Galan 3T XGO Edition offers the ability to conduct quick, comfortable and high-quality neuro imaging exams, and allows for faster sampling and higher-resolution images thanks to PURERF and Saturn technologies. This, combined with the ability to stack protocol sequences, results in quick neuro exams, enabling healthcare providers to produce higher resolution images for myriad neuro exams in under five minutes. The Galan 3T XGO Edition also offers Multiband SPEEDER technology, which allows for multiple slices to be acquired at the same time, reducing diffusion weighted imaging scan times by up to two times.

Beyond its neuro capabilities, the Galan 3T XGO Edition also offers enhanced cardiac imaging capabilities, including T1 mapping that utilizes MOdified Look-Locker Inversion recovery (MOLLI) sequence and allows providers to acquire a more quantitative characterization of myocardial tissue within a single breath hold. Additionally, Phase Sensitive Inversion Recovery (PSIR) in the heart provides improved contrast in late-enhanced imaging and eliminates the need for inversion time (TI) calibration scan, allowing cardiac exams to be completed with fewer breath holds and greater patient comfort.

For more information: www.medical.toshiba.com

 


Related Content

News | PET-MRI

June 10, 2026 — UTHealth Houston has launched a state-of-the-art PET/MRI imaging service, bringing together two advanced ...

Time June 12, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

June 4, 2026 — NordicNeuroLab has signed a comprehensive software license and distribution agreement with GE HealthCare ...

Time June 08, 2026
arrow
News | Innovative Hospitals

May 27, 2026 — Nearly two years after announcing plans for a “real-world” academic-industrial collaboration, GE ...

Time June 03, 2026
arrow
News | Nuclear Imaging

June 1, 2026 — At the 2026 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, GE HealthCare will ...

Time June 02, 2026
arrow
News | Cardiac Imaging

May 21, 2026 — A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s ...

Time May 22, 2026
arrow
News | Radiology Imaging

May 18, 2026 — DICO, a company specializing in the creation of distributed diagnostic infrastructure for radiology, has ...

Time May 19, 2026
arrow
News | Radiopharmaceuticals and Tracers

May 7, 2026 — Bayer has announced positive topline results from the Phase III REVEAL study, an investigator-initiated ...

Time May 08, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

May 4, 2026 — Esaote presented the latest developments of I-Genius* — an open MRI system designed to provide multiple ...

Time May 05, 2026
arrow
News | ASE

May 4, 2026 — The American Society of Echocardiography (ASE) has released a new guideline that provides guidance for ...

Time May 05, 2026
arrow
News | Imaging Software Development

April 28, 2026 — Avatar Medical has been granted FDA 510(k) clearance for Avatar Medical Vision, its software platform ...

Time April 28, 2026
arrow
Subscribe Now